Form 4: IFF Executive Simon Herriott Reports Acquisition of Restricted Stock Units

Simon Herriott, President of Health & Bioscience at International Flavors & Fragrances Inc., reports the acquisition of restricted stock units and common stock.

Summary

• On May 1, 2024, Simon Herriott, President of Health & Bioscience at International Flavors & Fragrances Inc. (IFF), acquired 8,930 Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
• These RSUs vest in three equal tranches: 2,976 shares on May 1, 2025, 2,976 shares on May 1, 2026, and 2,978 shares on May 1, 2027, contingent upon continued employment with IFF.
• Herriott also reported owning 9,034.257 shares of common stock directly.
• Additionally, the report indicates that shares were acquired during the period through a dividend reinvestment plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by an executive is generally a good sign, but it's a routine transaction.

Positives

• The acquisition of RSUs by a high-ranking executive could be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting schedule of the RSUs incentivizes continued employment with IFF, promoting stability within the leadership team.

Future Outlook

The vesting schedule of the RSUs suggests a commitment to IFF's future performance over the next three years.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units to align management's interests with those of shareholders.
• The vesting schedule of three years is a common practice in the industry to incentivize long-term commitment.
• Comparing Herriott's holdings and RSU grants to those of executives at similar companies like Givaudan, Firmenich (now dsm-firmenich), and Symrise would provide a benchmark for assessing the magnitude of his stake in IFF.

Stakeholder Impact

• The acquisition of RSUs by a key executive could positively influence shareholder confidence.
• The vesting schedule incentivizes the executive to remain with the company, which benefits employees and other stakeholders.

Key Dates